NR2F1 and Bosch-Boonstra-Schaaf optic atrophy syndrome: A total number of 47 individuals with a clinical phenotype of BBSOAS were enrolled in this study: 45 patients with molecularly confirmed BBSOAS (pathogenic/likely pathogenic variant in NR2F1) and two individuals with a variant of unknown significance.